-
1
-
-
4043181214
-
Cancer genes and the pathways they control
-
[CrossRef] [PubMed]
-
Vogelstein, B.; Kinzler, K.W. Cancer genes and the pathways they control. Nat. Med. 2004, 10, 789-799. [CrossRef] [PubMed]
-
(2004)
Nat. Med
, vol.10
, pp. 789-799
-
-
Vogelstein, B.1
Kinzler, K.W.2
-
2
-
-
0025312728
-
A genetic model for colorectal tumorigenesis
-
[CrossRef]
-
Fearon, E.R.; Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell 1990, 61, 759-767. [CrossRef]
-
(1990)
Cell
, vol.61
, pp. 759-767
-
-
Fearon, E.R.1
Vogelstein, B.2
-
3
-
-
69249087671
-
Environment-mediated drug resistance: A major contributor to minimal residual disease
-
[CrossRef] [PubMed]
-
Meads, M.B.; Gatenby, R.A.; Dalton, W.S. Environment-mediated drug resistance: A major contributor to minimal residual disease. Nat. Rev. Cancer 2009, 9, 665-674. [CrossRef] [PubMed]
-
(2009)
Nat. Rev. Cancer
, vol.9
, pp. 665-674
-
-
Meads, M.B.1
Gatenby, R.A.2
Dalton, W.S.3
-
4
-
-
3042822267
-
Cancer and the chemokine network
-
[CrossRef] [PubMed]
-
Balkwill, F. Cancer and the chemokine network. Nat. Rev. Cancer 2004, 4, 540-550. [CrossRef] [PubMed]
-
(2004)
Nat. Rev. Cancer
, vol.4
, pp. 540-550
-
-
Balkwill, F.1
-
5
-
-
0035282432
-
Involvement of chemokine receptors in breast cancer metastasis
-
[CrossRef] [PubMed]
-
Müller, A.; Homey, B.; Soto, H.; Ge, N.; Catron, D.; Buchanan, M.E.; McClanahan, T.; Murphy, E.; Yuan, W.; Wagner, S.N.; et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001, 140, 50-56. [CrossRef] [PubMed]
-
(2001)
Nature
, vol.140
, pp. 50-56
-
-
Müller, A.1
Homey, B.2
Soto, H.3
Ge, N.4
Catron, D.5
Buchanan, M.E.6
McClanahan, T.7
Murphy, E.8
Yuan, W.9
Wagner, S.N.10
-
6
-
-
63049104211
-
Microenvironmental regulation of metastasis
-
[CrossRef] [PubMed]
-
Joyce, J.A.; Pollard, J.W. Microenvironmental regulation of metastasis. Nat. Rev. Cancer 2009, 9, 239-252. [CrossRef] [PubMed]
-
(2009)
Nat. Rev. Cancer
, vol.9
, pp. 239-252
-
-
Joyce, J.A.1
Pollard, J.W.2
-
7
-
-
18844428327
-
Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion
-
[CrossRef] [PubMed]
-
Orimo, A.; Gupta, P.B.; Sgroi, D.C.; Arenzana-Seisdedos, F.; Delaunay, T.; Naeem, R.; Carey, V.J.; Richardson, A.L.; Weinberg, R.A. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 2005, 121, 335-348. [CrossRef] [PubMed]
-
(2005)
Cell
, vol.121
, pp. 335-348
-
-
Orimo, A.1
Gupta, P.B.2
Sgroi, D.C.3
Arenzana-Seisdedos, F.4
Delaunay, T.5
Naeem, R.6
Carey, V.J.7
Richardson, A.L.8
Weinberg, R.A.9
-
8
-
-
34948896045
-
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
-
[CrossRef] [PubMed]
-
Karnoub, A.E.; Dash, A.B.; Vo, A.P.; Sullivan, A.; Brooks, M.W.; Bell, G.W.; Richardson, A.L.; Polyak, K.; Tubo, R.; Weinerg, R.A. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 2007, 446, 557-563. [CrossRef] [PubMed]
-
(2007)
Nature
, vol.446
, pp. 557-563
-
-
Karnoub, A.E.1
Dash, A.B.2
Vo, A.P.3
Sullivan, A.4
Brooks, M.W.5
Bell, G.W.6
Richardson, A.L.7
Polyak, K.8
Tubo, R.9
Weinerg, R.A.10
-
9
-
-
68649089967
-
The role of bone-marrow-derived cells in tumor growth, metastasis initiation and progression
-
[CrossRef] [PubMed]
-
Gao, D.; Mittal, V. The role of bone-marrow-derived cells in tumor growth, metastasis initiation and progression. Trends Mol. Med. 2009, 15, 333-343. [CrossRef] [PubMed]
-
(2009)
Trends Mol. Med
, vol.15
, pp. 333-343
-
-
Gao, D.1
Mittal, V.2
-
10
-
-
47949090079
-
The role of myeloid cells in the promotion of tumour angiogenesis
-
[CrossRef] [PubMed]
-
Murdoch, C.; Muthana, M.; Coffelt, S.B.; Lewis, C.E. The role of myeloid cells in the promotion of tumour angiogenesis. Nat. Rev. Cancer 2008, 8, 618-631. [CrossRef] [PubMed]
-
(2008)
Nat. Rev. Cancer
, vol.8
, pp. 618-631
-
-
Murdoch, C.1
Muthana, M.2
Coffelt, S.B.3
Lewis, C.E.4
-
11
-
-
84858785703
-
Coordinated regulation of myeloid cells by tumours
-
[CrossRef] [PubMed]
-
Gabrilovich, D.I.; Ostrand-Rosenberg, S.; Bronte, V. Coordinated regulation of myeloid cells by tumours. Nat. Rev. Immunol. 2012, 12, 253-268. [CrossRef] [PubMed]
-
(2012)
Nat. Rev. Immunol
, vol.12
, pp. 253-268
-
-
Gabrilovich, D.I.1
Ostrand-Rosenberg, S.2
Bronte, V.3
-
12
-
-
84923027892
-
Immune cell promotion of metastasis
-
[CrossRef] [PubMed]
-
Kitamura, T.; Qian, B.Z.; Pollard, J.W. Immune cell promotion of metastasis. Nat. Rev. Immunol. 2015, 15, 73-86. [CrossRef] [PubMed]
-
(2015)
Nat. Rev. Immunol
, vol.15
, pp. 73-86
-
-
Kitamura, T.1
Qian, B.Z.2
Pollard, J.W.3
-
13
-
-
61349100687
-
Myeloid-derived suppressor cells as regulators of the immune system
-
[CrossRef] [PubMed]
-
Gabrilovich, D.I.; Nagaraj, S. Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 2009, 9, 162-174. [CrossRef] [PubMed]
-
(2009)
Nat. Rev. Immunol
, vol.9
, pp. 162-174
-
-
Gabrilovich, D.I.1
Nagaraj, S.2
-
14
-
-
84884556145
-
History of myeloid-derived suppressor cells
-
[CrossRef] [PubMed]
-
Talmadge, J.E.; Gabrilovich, D.I. History of myeloid-derived suppressor cells. Nat. Rev. Cancer 2013, 13, 739-752. [CrossRef] [PubMed]
-
(2013)
Nat. Rev. Cancer
, vol.13
, pp. 739-752
-
-
Talmadge, J.E.1
Gabrilovich, D.I.2
-
15
-
-
69249222379
-
Polarization of tumor-associated neutrophil phenotype by TGF-β: "N1" versus "N2" TAN
-
[CrossRef] [PubMed]
-
Fridlender, Z.G.; Sun, J.; Kim, S.; Kapoor, V.; Cheng, G.; Ling, L.; Worthen, G.S.; Albelda, S.M. Polarization of tumor-associated neutrophil phenotype by TGF-β: "N1" versus "N2" TAN. Cancer Cell 2009, 16, 183-194. [CrossRef] [PubMed]
-
(2009)
Cancer Cell
, vol.16
, pp. 183-194
-
-
Fridlender, Z.G.1
Sun, J.2
Kim, S.3
Kapoor, V.4
Cheng, G.5
Ling, L.6
Worthen, G.S.7
Albelda, S.M.8
-
16
-
-
79960829290
-
Neutrophils in the activation and regulation of innate and adaptive immunity
-
[CrossRef] [PubMed]
-
Mantovani, A.; Cassatella, M.A.; Costantini, C.; Jaillon, S. Neutrophils in the activation and regulation of innate and adaptive immunity. Nat. Rev. Immunol. 2011, 11, 519-531. [CrossRef] [PubMed]
-
(2011)
Nat. Rev. Immunol
, vol.11
, pp. 519-531
-
-
Mantovani, A.1
Cassatella, M.A.2
Costantini, C.3
Jaillon, S.4
-
17
-
-
84905164478
-
Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: A systematic review and meta-analysis
-
[CrossRef] [PubMed]
-
Templeton, A.J.; McNamara, M.G.; Šeruga, B.; Vera-Badillo, F.E.; Aneja, P.; Ocaña, A.; Leibowitz-Amit, R.; Sonpavde, G.; Knox, J.J.; Tran, B.; et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: A systematic review and meta-analysis. J. Natl. Cancer Inst. 2014, 106, dju124. [CrossRef] [PubMed]
-
(2014)
J. Natl. Cancer Inst
, vol.106
-
-
Templeton, A.J.1
McNamara, M.G.2
Šeruga, B.3
Vera-Badillo, F.E.4
Aneja, P.5
Ocaña, A.6
Leibowitz-Amit, R.7
Sonpavde, G.8
Knox, J.J.9
Tran, B.10
-
18
-
-
33846531356
-
The tumor microenvironment as a target for chemoprevention
-
[CrossRef] [PubMed]
-
Albini, A.; Sporn, M.B. The tumor microenvironment as a target for chemoprevention. Nat. Rev. Cancer 2007, 7, 139-147. [CrossRef] [PubMed]
-
(2007)
Nat. Rev. Cancer
, vol.7
, pp. 139-147
-
-
Albini, A.1
Sporn, M.B.2
-
19
-
-
33645850713
-
CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer
-
[CrossRef] [PubMed]
-
Wang, D.; Wang, H.; Brown, J.; Daikoku, T.; Ning, W.; Shi, Q.; Richmond, A.; Strieter, R.; Dey, S.K.; DuBois, R.N. CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer. J. Exp. Med. 2006, 203, 941-951. [CrossRef] [PubMed]
-
(2006)
J. Exp. Med
, vol.203
, pp. 941-951
-
-
Wang, D.1
Wang, H.2
Brown, J.3
Daikoku, T.4
Ning, W.5
Shi, Q.6
Richmond, A.7
Strieter, R.8
Dey, S.K.9
DuBois, R.N.10
-
20
-
-
57149106131
-
TSU68 prevents liver metastasis of colon cancer xenografts by modulating the premetastatic niche
-
[CrossRef] [PubMed]
-
Yamamoto, M.; Kikuchi, H.; Ohta, M.; Kawabata, T.; Hiramatsu, Y.; Kondo, K.; Baba, M.; Kamiya, K.; Tanaka, T.; Kitagawa, M.; et al. TSU68 prevents liver metastasis of colon cancer xenografts by modulating the premetastatic niche. Cancer Res. 2008, 68, 9754-9762. [CrossRef] [PubMed]
-
(2008)
Cancer Res
, vol.68
, pp. 9754-9762
-
-
Yamamoto, M.1
Kikuchi, H.2
Ohta, M.3
Kawabata, T.4
Hiramatsu, Y.5
Kondo, K.6
Baba, M.7
Kamiya, K.8
Tanaka, T.9
Kitagawa, M.10
-
21
-
-
84887512876
-
CXCR2-expressing myeloid-derived suppressor cells are essential to promote colitis-associated tumorigenesis
-
[CrossRef] [PubMed]
-
Katoh, H.; Wang, D.; Daikoku, T.; Sun, H.; Dey, S.K.; DuBois, R.N. CXCR2-expressing myeloid-derived suppressor cells are essential to promote colitis-associated tumorigenesis. Cancer Cell 2013, 24, 631-644. [CrossRef] [PubMed]
-
(2013)
Cancer Cell
, vol.24
, pp. 631-644
-
-
Katoh, H.1
Wang, D.2
Daikoku, T.3
Sun, H.4
Dey, S.K.5
DuBois, R.N.6
-
22
-
-
34447524931
-
Chemokine receptor CXCR3 promotes colon cancer metastasis to lymph nodes
-
[CrossRef] [PubMed]
-
Kawada, K.; Hosogi, H.; Sonoshita, M.; Sakashita, H.; Manabe, T.; Shimahara, Y.; Sakai, Y.; Takabayashi, A.; Oshima, M.; Taketo, M.M. Chemokine receptor CXCR3 promotes colon cancer metastasis to lymph nodes. Oncogene 2007, 26, 4679-4688. [CrossRef] [PubMed]
-
(2007)
Oncogene
, vol.26
, pp. 4679-4688
-
-
Kawada, K.1
Hosogi, H.2
Sonoshita, M.3
Sakashita, H.4
Manabe, T.5
Shimahara, Y.6
Sakai, Y.7
Takabayashi, A.8
Oshima, M.9
Taketo, M.M.10
-
23
-
-
84869506748
-
The role of CXCR3 and CXCR4 in colorectal cancer metastasis
-
[CrossRef] [PubMed]
-
Murakami, T.; Kawada, K.; Iwamoto, M.; Akagami, M.; Hida, K.; Nakanishi, Y.; Kanda, K.; Kawada, M.; Seno, H.; Taketo, M.M.; et al. The role of CXCR3 and CXCR4 in colorectal cancer metastasis. Int. J. Cancer 2013, 132, 276-287. [CrossRef] [PubMed]
-
(2013)
Int. J. Cancer
, vol.132
, pp. 276-287
-
-
Murakami, T.1
Kawada, K.2
Iwamoto, M.3
Akagami, M.4
Hida, K.5
Nakanishi, Y.6
Kanda, K.7
Kawada, M.8
Seno, H.9
Taketo, M.M.10
-
24
-
-
23944469303
-
+ T lymphocytes in human colorectal carcinoma
-
[CrossRef] [PubMed]
-
+ T lymphocytes in human colorectal carcinoma. Int. J. Cancer 2005, 116, 949-956. [CrossRef] [PubMed]
-
(2005)
Int. J. Cancer
, vol.116
, pp. 949-956
-
-
Musha, H.1
Ohtani, H.2
Mizoi, T.3
Kinouchi, M.4
Nakayama, T.5
Shiiba, K.6
Miyagawa, K.7
Nagura, H.8
Yoshie, O.9
Ssaki, I.10
-
25
-
-
18444401114
-
Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival
-
[CrossRef] [PubMed]
-
Kim, J.; Takeuchi, H.; Lam, S.T.; Turner, R.R.; Wang, H.J.; Kuo, C.; Foshag, L.; Bilchik, A.J.; Hoon, D.S. Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival. J. Clin. Oncol. 2005, 23, 2744-2753. [CrossRef] [PubMed]
-
(2005)
J. Clin. Oncol
, vol.23
, pp. 2744-2753
-
-
Kim, J.1
Takeuchi, H.2
Lam, S.T.3
Turner, R.R.4
Wang, H.J.5
Kuo, C.6
Foshag, L.7
Bilchik, A.J.8
Hoon, D.S.9
-
26
-
-
33646734034
-
Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients
-
[CrossRef] [PubMed]
-
Ottaiano, A.; Franco, R.; Aiello Talamanca, A.; Liguori, G.; Tatangelo, F.; Delrio, P.; Nasti, G.; Barletta, E.; Facchini, G.; Daniele, B.; et al. Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients. Clin. Cancer Res. 2006, 12, 2795-2803. [CrossRef] [PubMed]
-
(2006)
Clin. Cancer Res
, vol.12
, pp. 2795-2803
-
-
Ottaiano, A.1
Franco, R.2
Aiello Talamanca, A.3
Liguori, G.4
Tatangelo, F.5
Delrio, P.6
Nasti, G.7
Barletta, E.8
Facchini, G.9
Daniele, B.10
-
27
-
-
20144389538
-
Effect of chemokine receptors CXCR4 and CCR7 on the metastasis behavior of human colorectal cancer
-
[CrossRef] [PubMed]
-
Schimanski, C.C.; Schwald, S.; Simiantonaki, N.; Jayasinghe, C.; Gönner, U.; Wilsberg, V.; Junginger, T.; Berger, M.R.; Galle, P.R.; Moehler, M. Effect of chemokine receptors CXCR4 and CCR7 on the metastasis behavior of human colorectal cancer. Clin. Cancer Res. 2005, 11, 1743-1750. [CrossRef] [PubMed]
-
(2005)
Clin. Cancer Res
, vol.11
, pp. 1743-1750
-
-
Schimanski, C.C.1
Schwald, S.2
Simiantonaki, N.3
Jayasinghe, C.4
Gönner, U.5
Wilsberg, V.6
Junginger, T.7
Berger, M.R.8
Galle, P.R.9
Moehler, M.10
-
28
-
-
84865020846
-
CXCR4 expression predicts patient outcome and recurrence patterns after hepatic resection for colorectal liver metastases
-
[CrossRef] [PubMed]
-
Yopp, A.C.; Shia, J.; Butte, J.M.; Allen, P.J.; Fong, Y.; Jarnagin, W.R.; DeMatteo, R.P.; D'Angelica, M.I. CXCR4 expression predicts patient outcome and recurrence patterns after hepatic resection for colorectal liver metastases. Ann. Surg. Oncol. 2012, 19 (Suppl. S3), S339-S346. [CrossRef] [PubMed]
-
(2012)
Ann. Surg. Oncol
, vol.19
, pp. S339-S346
-
-
Yopp, A.C.1
Shia, J.2
Butte, J.M.3
Allen, P.J.4
Fong, Y.5
Jarnagin, W.R.6
DeMatteo, R.P.7
D'Angelica, M.I.8
-
29
-
-
68949200810
-
Hepatic stellate cells promote liver metastasis of colon cancer cells by the action of SDF-1/CXCR4 axis
-
[CrossRef] [PubMed]
-
Matsusue, R.; Kubo, H.; Hisamori, S.; Okoshi, K.; Takagi, H.; Hida, K.; Nakano, K.; Itami, A.; Kawada, K.; Nagayama, S.; et al. Hepatic stellate cells promote liver metastasis of colon cancer cells by the action of SDF-1/CXCR4 axis. Ann. Surg. Oncol. 2009, 16, 2645-2653. [CrossRef] [PubMed]
-
(2009)
Ann. Surg. Oncol
, vol.16
, pp. 2645-2653
-
-
Matsusue, R.1
Kubo, H.2
Hisamori, S.3
Okoshi, K.4
Takagi, H.5
Hida, K.6
Nakano, K.7
Itami, A.8
Kawada, K.9
Nagayama, S.10
-
30
-
-
67650457700
-
CXCR4 regulates the early extravasation of metastatic tumor cells in vivo
-
[CrossRef] [PubMed]
-
Gassmann, P.; Haier, J.; Schlüter, K.; Domikowsky, B.; Wendel, C.; Wiesner, U.; Kubitza, R.; Engers, R.; Schneider, S.W.; Homey, B.; et al. CXCR4 regulates the early extravasation of metastatic tumor cells in vivo. Neoplasia 2009, 11, 651-661. [CrossRef] [PubMed]
-
(2009)
Neoplasia
, vol.11
, pp. 651-661
-
-
Gassmann, P.1
Haier, J.2
Schlüter, K.3
Domikowsky, B.4
Wendel, C.5
Wiesner, U.6
Kubitza, R.7
Engers, R.8
Schneider, S.W.9
Homey, B.10
-
31
-
-
68549096319
-
Prognostic significance of CXCL12 expression in patients with colorectal carcinoma
-
[CrossRef] [PubMed]
-
Akishima-Fukasawa, Y.; Nakanishi, Y.; Ino, Y.; Moriya, Y.; Kanai, Y.; Hirohashi, S. Prognostic significance of CXCL12 expression in patients with colorectal carcinoma. Am. J. Clin. Pathol. 2009, 132, 202-210. [CrossRef] [PubMed]
-
(2009)
Am. J. Clin. Pathol
, vol.132
, pp. 202-210
-
-
Akishima-Fukasawa, Y.1
Nakanishi, Y.2
Ino, Y.3
Moriya, Y.4
Kanai, Y.5
Hirohashi, S.6
-
32
-
-
34247576326
-
Chemokine expression is associated with the accumulation of tumor associated macrophages (TAMs) and progression in human colorectal cancer
-
[CrossRef] [PubMed]
-
Bailey, C.; Negus, R.; Morris, A.; Ziprin, P.; Goldin, R.; Allavena, P.; Peck, D.; Darzi, A. Chemokine expression is associated with the accumulation of tumor associated macrophages (TAMs) and progression in human colorectal cancer. Clin. Exp. Metastasis 2007, 2, 121-130. [CrossRef] [PubMed]
-
(2007)
Clin. Exp. Metastasis
, vol.2
, pp. 121-130
-
-
Bailey, C.1
Negus, R.2
Morris, A.3
Ziprin, P.4
Goldin, R.5
Allavena, P.6
Peck, D.7
Darzi, A.8
-
33
-
-
69949092197
-
Tumor cell-microenvironment interaction models coupled with clinical validation reveal CCL2 and SNCG as two predictors of colorectal cancer hepatic metastasis
-
[CrossRef] [PubMed]
-
Hu, H.; Sun, L.; Guo, C.; Liu, Q.; Zhou, Z.; Peng, L.; Pan, J.; Yu, L.; Lou, J.; Yang, Z.; et al. Tumor cell-microenvironment interaction models coupled with clinical validation reveal CCL2 and SNCG as two predictors of colorectal cancer hepatic metastasis. Clin. Cancer Res. 2009, 15, 5485-5593. [CrossRef] [PubMed]
-
(2009)
Clin. Cancer Res
, vol.15
, pp. 5485-5593
-
-
Hu, H.1
Sun, L.2
Guo, C.3
Liu, Q.4
Zhou, Z.5
Peng, L.6
Pan, J.7
Yu, L.8
Lou, J.9
Yang, Z.10
-
34
-
-
84873303427
-
mid) via CCL2/CCR2 promotes the development of colorectal cancer liver metastasis
-
[CrossRef] [PubMed]
-
mid) via CCL2/CCR2 promotes the development of colorectal cancer liver metastasis. Hepatology 2013, 57, 829-839. [CrossRef] [PubMed]
-
(2013)
Hepatology
, vol.57
, pp. 829-839
-
-
Zhao, L.1
Lim, S.Y.2
Gordon-Weeks, A.N.3
Tapmeier, T.T.4
Im, J.H.5
Cao, Y.6
Beech, J.7
Allen, D.8
Smart, S.9
Muschel, R.J.10
-
35
-
-
84937519151
-
CCL2 Promotes Colorectal Carcinogenesis by Enhancing Polymorphonuclear Myeloid-Derived Suppressor Cell Population and Function
-
[CrossRef] [PubMed]
-
Chun, E.; Lavoie, S.; Michaud, M.; Gallini, C.A.; Kim, J.; Soucy, G.; Odze, R.; Glickman, J.N.; Garrett, W.S. CCL2 Promotes Colorectal Carcinogenesis by Enhancing Polymorphonuclear Myeloid-Derived Suppressor Cell Population and Function. Cell Rep. 2015, 12, 244-257. [CrossRef] [PubMed]
-
(2015)
Cell Rep
, vol.12
, pp. 244-257
-
-
Chun, E.1
Lavoie, S.2
Michaud, M.3
Gallini, C.A.4
Kim, J.5
Soucy, G.6
Odze, R.7
Glickman, J.N.8
Garrett, W.S.9
-
36
-
-
84863756518
-
Endothelial CCR2 signaling induced by colon carcinoma cells enables extravasation via the JAK2-Stat5 and p38MAPK pathway
-
[CrossRef] [PubMed]
-
Wolf, M.J.; Hoos, A.; Bauer, J.; Boettcher, S.; Knust, M.; Weber, A.; Simonavicius, N.; Schneider, C.; Lang, M.; Stürzl, M.; et al. Endothelial CCR2 signaling induced by colon carcinoma cells enables extravasation via the JAK2-Stat5 and p38MAPK pathway. Cancer Cell 2012, 22, 91-105. [CrossRef] [PubMed]
-
(2012)
Cancer Cell
, vol.22
, pp. 91-105
-
-
Wolf, M.J.1
Hoos, A.2
Bauer, J.3
Boettcher, S.4
Knust, M.5
Weber, A.6
Simonavicius, N.7
Schneider, C.8
Lang, M.9
Stürzl, M.10
-
37
-
-
84863274470
-
+ T cells in colon cancer by T-regulatory cells
-
[CrossRef] [PubMed]
-
+ T cells in colon cancer by T-regulatory cells. Cancer Res. 2012, 72, 1092-1102. [CrossRef] [PubMed]
-
(2012)
Cancer Res
, vol.72
, pp. 1092-1102
-
-
Chang, L.Y.1
Lin, Y.C.2
Mahalingam, J.3
Huang, C.T.4
Chen, T.W.5
Kang, C.W.6
Peng, H.M.7
Chu, Y.Y.8
Chiang, J.M.9
Dutta, A.10
-
38
-
-
34047138860
-
+ myeloid cells that promote invasion
-
[CrossRef] [PubMed]
-
+ myeloid cells that promote invasion. Nat. Genet. 2007, 39, 467-475. [CrossRef] [PubMed]
-
(2007)
Nat. Genet
, vol.39
, pp. 467-475
-
-
Kitamura, T.1
Kometani, K.2
Hashida, H.3
Matsunaga, A.4
Miyoshi, H.5
Hosogi, H.6
Aoki, M.7
Oshima, M.8
Hattori, M.9
Takabayashi, A.10
-
39
-
-
77955640339
-
Inactivation of Chemokine (C-C motif) receptor 1 (CCR1) suppresses colon cancer liver metastasis by blocking accumulation of immature myeloid cells in a mouse model
-
[CrossRef] [PubMed]
-
Kitamura, T.; Fujishita, T.; Loestcher, P.; Revesz, L.; Hashida, H.; Kizaka-Kondoh, S.; Aoki, M.; Taketo, M.M. Inactivation of Chemokine (C-C motif) receptor 1 (CCR1) suppresses colon cancer liver metastasis by blocking accumulation of immature myeloid cells in a mouse model. Proc. Natl. Acad. Sci. USA 2010, 107, 13063-13068. [CrossRef] [PubMed]
-
(2010)
Proc. Natl. Acad. Sci. USA
, vol.107
, pp. 13063-13068
-
-
Kitamura, T.1
Fujishita, T.2
Loestcher, P.3
Revesz, L.4
Hashida, H.5
Kizaka-Kondoh, S.6
Aoki, M.7
Taketo, M.M.8
-
40
-
-
84886789666
-
+ myeloid cells and facilitate liver metastasis
-
[CrossRef] [PubMed]
-
+ myeloid cells and facilitate liver metastasis. Gastroenterology 2013, 145, 1064-1075. [CrossRef] [PubMed]
-
(2013)
Gastroenterology
, vol.145
, pp. 1064-1075
-
-
Itatani, Y.1
Kawada, K.2
Fujishita, T.3
Kakizaki, F.4
Hirai, H.5
Matsumoto, T.6
Iwamoto, M.7
Inamoto, S.8
Hatano, E.9
Hasegawa, S.10
-
41
-
-
84917676700
-
CCR1-mediated accumulation of myeloid cells in the liver microenvironment promoting mouse colon cancer metastasis
-
[CrossRef] [PubMed]
-
Hirai, H.; Fujishita, T.; Kurimoto, K.; Miyachi, H.; Kitano, S.; Inamoto, S.; Itatani, Y.; Saitou, M.; Maekawa, T.; Taketo, M.M. CCR1-mediated accumulation of myeloid cells in the liver microenvironment promoting mouse colon cancer metastasis. Clin. Exp. Metastasis 2014, 31, 977-989. [CrossRef] [PubMed]
-
(2014)
Clin. Exp. Metastasis
, vol.31
, pp. 977-989
-
-
Hirai, H.1
Fujishita, T.2
Kurimoto, K.3
Miyachi, H.4
Kitano, S.5
Inamoto, S.6
Itatani, Y.7
Saitou, M.8
Maekawa, T.9
Taketo, M.M.10
-
42
-
-
84959016957
-
Loss of SMAD4 promotes colorectal cancer progression by accumulation of myeloid-derived suppressor cells through CCL15-CCR1 chemokine axis
-
[CrossRef] [PubMed]
-
Inamoto, S.; Itatani, Y.; Yamamoto, T.; Minamiguchi, S.; Hirai, H.; Iwamoto, M.; Hasegawa, S.; Taketo, M.M.; Sakai, Y.; Kawada, K. Loss of SMAD4 promotes colorectal cancer progression by accumulation of myeloid-derived suppressor cells through CCL15-CCR1 chemokine axis. Clin. Cancer Res. 2016, 22, 492-501. [CrossRef] [PubMed]
-
(2016)
Clin. Cancer Res
, vol.22
, pp. 492-501
-
-
Inamoto, S.1
Itatani, Y.2
Yamamoto, T.3
Minamiguchi, S.4
Hirai, H.5
Iwamoto, M.6
Hasegawa, S.7
Taketo, M.M.8
Sakai, Y.9
Kawada, K.10
-
43
-
-
79955774902
-
+ regulatory T cells and promote the development of colorectal cancer via enhancing CCL20 production in mice
-
[CrossRef] [PubMed]
-
+ regulatory T cells and promote the development of colorectal cancer via enhancing CCL20 production in mice. PLoS ONE 2011, 6, e19495. [CrossRef] [PubMed]
-
(2011)
PLoS ONE
, vol.6
-
-
Liu, J.1
Zhang, N.2
Li, Q.3
Zhang, W.4
Ke, F.5
Leng, Q.6
Wang, H.7
Chen, J.8
Wang, H.9
-
44
-
-
0038375013
-
+ memory T-cell subsets in response to antigen or homeostatic cytokines
-
[CrossRef] [PubMed]
-
+ memory T-cell subsets in response to antigen or homeostatic cytokines. Blood 2003, 101, 4260-4266. [CrossRef] [PubMed]
-
(2003)
Blood
, vol.101
, pp. 4260-4266
-
-
Geginat, J.1
Lanzavecchia, A.2
Sallusto, F.3
-
45
-
-
84890258401
-
IL-18-based combinatorial adjuvants promote the intranodal production of CCL19 by NK cells and dendritic cells of cancer patients
-
[CrossRef] [PubMed]
-
Wong, J.L.; Muthuswamy, R.; Bartlett, D.L.; Kalinski, P. IL-18-based combinatorial adjuvants promote the intranodal production of CCL19 by NK cells and dendritic cells of cancer patients. Oncoimmunology 2013, 2, e26245. [CrossRef] [PubMed]
-
(2013)
Oncoimmunology
, vol.2
-
-
Wong, J.L.1
Muthuswamy, R.2
Bartlett, D.L.3
Kalinski, P.4
-
46
-
-
84887642718
-
Chemokine receptor CX3CR1 contributes to macrophage survival in tumor metastasis
-
[CrossRef] [PubMed]
-
Zheng, J.; Yang, M.; Shao, J.; Miao, Y.; Han, J.; Du, J. Chemokine receptor CX3CR1 contributes to macrophage survival in tumor metastasis. Mol. Cancer 2013, 12. [CrossRef] [PubMed]
-
(2013)
Mol. Cancer
, pp. 12
-
-
Zheng, J.1
Yang, M.2
Shao, J.3
Miao, Y.4
Han, J.5
Du, J.6
-
47
-
-
78650563018
-
Autocrine TGF-β and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts
-
[CrossRef] [PubMed]
-
Kojima, Y.; Acar, A.; Eaton, E.N.; Mellody, K.T.; Scheel, C.; Ben-Porath, I.; Onder, T.T.; Wang, Z.C.; Richardson, A.L.; Weinberg, R.A.; et al. Autocrine TGF-β and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts. Proc. Natl. Acad. Sci. USA 2010, 107, 20009-20014. [CrossRef] [PubMed]
-
(2010)
Proc. Natl. Acad. Sci. USA
, vol.107
, pp. 20009-20014
-
-
Kojima, Y.1
Acar, A.2
Eaton, E.N.3
Mellody, K.T.4
Scheel, C.5
Ben-Porath, I.6
Onder, T.T.7
Wang, Z.C.8
Richardson, A.L.9
Weinberg, R.A.10
-
48
-
-
84897479412
-
Hypoxia differentially regulated CXCR4 and CXCR7 signaling in colon cancer
-
[CrossRef] [PubMed]
-
Romain, B.; Hachet-Haas, M.; Rohr, S.; Brigand, C.; Galzi, J.L.; Gaub, M.P.; Pencreach, E.; Guenot, D. Hypoxia differentially regulated CXCR4 and CXCR7 signaling in colon cancer. Mol. Cancer 2014. [CrossRef] [PubMed]
-
(2014)
Mol. Cancer
-
-
Romain, B.1
Hachet-Haas, M.2
Rohr, S.3
Brigand, C.4
Galzi, J.L.5
Gaub, M.P.6
Pencreach, E.7
Guenot, D.8
-
49
-
-
33747371948
-
Silencing of epithelial CXCL12 expression by DNA hypermethylation promotes colonic carcinoma metastasis
-
[CrossRef] [PubMed]
-
Wendt, M.K.; Johanesen, P.A.; Kang-Decker, N.; Binion, D.G.; Shah, V.; Dwinell, M.B. Silencing of epithelial CXCL12 expression by DNA hypermethylation promotes colonic carcinoma metastasis. Oncogene 2006, 25, 4986-4997. [CrossRef] [PubMed]
-
(2006)
Oncogene
, vol.25
, pp. 4986-4997
-
-
Wendt, M.K.1
Johanesen, P.A.2
Kang-Decker, N.3
Binion, D.G.4
Shah, V.5
Dwinell, M.B.6
-
50
-
-
25844480604
-
CXCR4 and CXCL12 are inversely expressed in colorectal cancer cells and modulate cancer cell migration, invasion and MMP-9 activation
-
[CrossRef] [PubMed]
-
Brand, S.; Dambacher, J.; Beigel, F.; Olszak, T.; Diebold, J.; Otte, J.M.; Göke, B.; Eichhorst, S.T. CXCR4 and CXCL12 are inversely expressed in colorectal cancer cells and modulate cancer cell migration, invasion and MMP-9 activation. Exp. Cell Res. 2005, 310, 117-130. [CrossRef] [PubMed]
-
(2005)
Exp. Cell Res
, vol.310
, pp. 117-130
-
-
Brand, S.1
Dambacher, J.2
Beigel, F.3
Olszak, T.4
Diebold, J.5
Otte, J.M.6
Göke, B.7
Eichhorst, S.T.8
-
51
-
-
84862269804
-
Modulating the interaction of CXCR4 and CXCL12 by low-molecular-weight heparin inhibits hepatic metastasis of colon cancer
-
[CrossRef] [PubMed]
-
Ma, L.; Qiao, H.; He, C.; Yang, Q.; Cheung, C.H.; Kanwar, J.R.; Sun, X. Modulating the interaction of CXCR4 and CXCL12 by low-molecular-weight heparin inhibits hepatic metastasis of colon cancer. Investig. New Drugs 2012, 30, 508-517. [CrossRef] [PubMed]
-
(2012)
Investig. New Drugs
, vol.30
, pp. 508-517
-
-
Ma, L.1
Qiao, H.2
He, C.3
Yang, Q.4
Cheung, C.H.5
Kanwar, J.R.6
Sun, X.7
-
52
-
-
79954606458
-
CXCL12 (SDF1α)-CXCR4/CXCR7 pathway inhibition: An emerging sensitizer for anticancer therapies?
-
[CrossRef] [PubMed]
-
Duda, D.G.; Kozin, S.V.; Kirkpatrick, N.D.; Xu, L.; Fukumura, D.; Jain, R.K. CXCL12 (SDF1α)-CXCR4/CXCR7 pathway inhibition: An emerging sensitizer for anticancer therapies? Clin. Cancer Res. 2011, 17, 2074-2080. [CrossRef] [PubMed]
-
(2011)
Clin. Cancer Res
, vol.17
, pp. 2074-2080
-
-
Duda, D.G.1
Kozin, S.V.2
Kirkpatrick, N.D.3
Xu, L.4
Fukumura, D.5
Jain, R.K.6
-
53
-
-
39849102836
-
HIF1α induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion
-
[CrossRef] [PubMed]
-
Du, R.; Lu, K.V.; Petritsch, C.; Liu, P.; Ganss, R.; Passegué, E.; Song, H.; Vandenberg, S.; Johnson, R.S.; Werb, Z.; et al. HIF1α induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. Cancer Cell 2008, 13, 206-220. [CrossRef] [PubMed]
-
(2008)
Cancer Cell
, vol.13
, pp. 206-220
-
-
Du, R.1
Lu, K.V.2
Petritsch, C.3
Liu, P.4
Ganss, R.5
Passegué, E.6
Song, H.7
Vandenberg, S.8
Johnson, R.S.9
Werb, Z.10
-
54
-
-
78651109040
-
C-X-C receptor type 4 promotes metastasis by activating p38 mitogen-activated protein kinase in myeloid differentiation antigen (Gr-1)-positive cells
-
[CrossRef] [PubMed]
-
Hiratsuka, S.; Duda, D.G.; Huang, Y.; Goel, S.; Sugiyama, T.; Nagasawa, T.; Fukumura, D.; Jain, R.K. C-X-C receptor type 4 promotes metastasis by activating p38 mitogen-activated protein kinase in myeloid differentiation antigen (Gr-1)-positive cells. Proc. Natl. Acad. Sci. USA 2011, 108, 302-307. [CrossRef] [PubMed]
-
(2011)
Proc. Natl. Acad. Sci. USA
, vol.108
, pp. 302-307
-
-
Hiratsuka, S.1
Duda, D.G.2
Huang, Y.3
Goel, S.4
Sugiyama, T.5
Nagasawa, T.6
Fukumura, D.7
Jain, R.K.8
-
55
-
-
28644432204
-
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
-
[CrossRef] [PubMed]
-
Kaplan, R.N.; Riba, R.D.; Zacharoulis, S.; Bramley, A.H.; Vincent, L.; Costa, C.; MacDonald, D.D.; Jin, D.K.; Shido, K.; Kerns, S.A.; et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 2005, 438, 820-827. [CrossRef] [PubMed]
-
(2005)
Nature
, vol.438
, pp. 820-827
-
-
Kaplan, R.N.1
Riba, R.D.2
Zacharoulis, S.3
Bramley, A.H.4
Vincent, L.5
Costa, C.6
MacDonald, D.D.7
Jin, D.K.8
Shido, K.9
Kerns, S.A.10
-
56
-
-
84882990634
-
Development and preclinical characterization of a humanized antibody targeting CXCL12
-
[CrossRef] [PubMed]
-
Zhong, C.; Wang, J.; Li, B.; Xiang, H.; Ultsch, M.; Coons, M.; Wong, T.; Chiang, N.Y.; Clark, S.; Clark, R.; et al. Development and preclinical characterization of a humanized antibody targeting CXCL12. Clin. Cancer Res. 2013, 19, 4433-4445. [CrossRef] [PubMed]
-
(2013)
Clin. Cancer Res
, vol.19
, pp. 4433-4445
-
-
Zhong, C.1
Wang, J.2
Li, B.3
Xiang, H.4
Ultsch, M.5
Coons, M.6
Wong, T.7
Chiang, N.Y.8
Clark, S.9
Clark, R.10
-
57
-
-
2542612840
-
Pivotal role of CXCR3 in melanoma cell metastasis to lymph nodes
-
[CrossRef] [PubMed]
-
Kawada, K.; Sonoshita, M.; Sakashita, H.; Takabayashi, A.; Yamaoka, Y.; Manabe, T.; Inaba, K.; Minato, N.; Oshima, M.; Taketo, M.M. Pivotal role of CXCR3 in melanoma cell metastasis to lymph nodes. Cancer Res. 2004, 64, 4010-4017. [CrossRef] [PubMed]
-
(2004)
Cancer Res
, vol.64
, pp. 4010-4017
-
-
Kawada, K.1
Sonoshita, M.2
Sakashita, H.3
Takabayashi, A.4
Yamaoka, Y.5
Manabe, T.6
Inaba, K.7
Minato, N.8
Oshima, M.9
Taketo, M.M.10
-
58
-
-
79951846893
-
Significance and mechanism of lymph node metastasis in cancer progression
-
[CrossRef] [PubMed]
-
Kawada, K.; Taketo, M.M. Significance and mechanism of lymph node metastasis in cancer progression. Cancer Res. 2011, 71, 1214-1218. [CrossRef] [PubMed]
-
(2011)
Cancer Res
, vol.71
, pp. 1214-1218
-
-
Kawada, K.1
Taketo, M.M.2
-
59
-
-
34248220334
-
CXCL10 promotes invasion-related properties in human colorectal carcinoma cells
-
[CrossRef] [PubMed]
-
Zipin-Roitman, A.; Meshel, T.; Sagi-Assif, O.; Shalmon, B.; Avivi, C.; Pfeffer, R.M.; Witz, I.P.; Ben-Baruch, A. CXCL10 promotes invasion-related properties in human colorectal carcinoma cells. Cancer Res. 2007, 67, 3396-3405. [CrossRef] [PubMed]
-
(2007)
Cancer Res
, vol.67
, pp. 3396-3405
-
-
Zipin-Roitman, A.1
Meshel, T.2
Sagi-Assif, O.3
Shalmon, B.4
Avivi, C.5
Pfeffer, R.M.6
Witz, I.P.7
Ben-Baruch, A.8
-
60
-
-
27744565065
-
Clinical significance of CXCR3 and CXCR4 expression in primary melanoma
-
[CrossRef] [PubMed]
-
Longo-Imedio, M.I.; Longo, N.; Trevino, I.; Lazaro, P.; Sanchez-Mateos, P. Clinical significance of CXCR3 and CXCR4 expression in primary melanoma. Int. J. Cancer 2005, 117, 861-865. [CrossRef] [PubMed]
-
(2005)
Int. J. Cancer
, vol.117
, pp. 861-865
-
-
Longo-Imedio, M.I.1
Longo, N.2
Trevino, I.3
Lazaro, P.4
Sanchez-Mateos, P.5
-
61
-
-
66449121642
-
CXCR3 expression is associated with poor survival in breast cancer and promotes metastasis in a murine model
-
[CrossRef] [PubMed]
-
Ma, X.; Norsworthy, K.; Kundu, N.; Rodgers, W.H.; Gimotty, P.A.; Goloubeva, O.; Lipsky, M.; Li, Y.; Holt, D.; Fulton, A. CXCR3 expression is associated with poor survival in breast cancer and promotes metastasis in a murine model. Mol. Cancer Ther. 2009, 8, 490-498. [CrossRef] [PubMed]
-
(2009)
Mol. Cancer Ther
, vol.8
, pp. 490-498
-
-
Ma, X.1
Norsworthy, K.2
Kundu, N.3
Rodgers, W.H.4
Gimotty, P.A.5
Goloubeva, O.6
Lipsky, M.7
Li, Y.8
Holt, D.9
Fulton, A.10
-
62
-
-
67349193581
-
Organ-specific inhibition of metastatic colon carcinoma by CXCR3 antagonism
-
[CrossRef] [PubMed]
-
Cambien, B.; Karimdjee, B.F.; Richard-Fiardo, P.; Bziouech, H.; Barthel, R.; Millet, M.A.; Martini, V.; Birnbaum, D.; Scoazec, J.Y.; Abello, J.; et al. Organ-specific inhibition of metastatic colon carcinoma by CXCR3 antagonism. Br. J. Cancer 2009, 100, 1755-1764. [CrossRef] [PubMed]
-
(2009)
Br. J. Cancer
, vol.100
, pp. 1755-1764
-
-
Cambien, B.1
Karimdjee, B.F.2
Richard-Fiardo, P.3
Bziouech, H.4
Barthel, R.5
Millet, M.A.6
Martini, V.7
Birnbaum, D.8
Scoazec, J.Y.9
Abello, J.10
-
63
-
-
33747888160
-
Antagonism of CXCR3 inhibits lung metastasis in a murine model of metastatic breast cancer
-
[CrossRef] [PubMed]
-
Walser, T.C.; Rifat, S.; Ma, X.; Kundu, N.; Ward, C.; Goloubeva, O.; Johnson, M.G.; Mediana, J.C.; Colloins, T.L.; Fulton, A.M. Antagonism of CXCR3 inhibits lung metastasis in a murine model of metastatic breast cancer. Cancer Res. 2006, 66, 7701-7707. [CrossRef] [PubMed]
-
(2006)
Cancer Res
, vol.66
, pp. 7701-7707
-
-
Walser, T.C.1
Rifat, S.2
Ma, X.3
Kundu, N.4
Ward, C.5
Goloubeva, O.6
Johnson, M.G.7
Mediana, J.C.8
Colloins, T.L.9
Fulton, A.M.10
-
64
-
-
84952914173
-
CXCR3 as a molecular target in breast cancer metastasis: Inhibition of tumor cell migration and promotion of host anti-tumor immunity
-
[PubMed]
-
Zhu, G.; Yan, H.H.; Pang, Y.; Jian, J.; Achyut, B.R.; Liang, X.; Weiss, J.M.; Wiltrout, R.H.; Hollander, M.C.; Yang, L. CXCR3 as a molecular target in breast cancer metastasis: Inhibition of tumor cell migration and promotion of host anti-tumor immunity. Oncotarget 2015, 6, 43408-43419. [PubMed]
-
(2015)
Oncotarget
, vol.6
, pp. 43408-43419
-
-
Zhu, G.1
Yan, H.H.2
Pang, Y.3
Jian, J.4
Achyut, B.R.5
Liang, X.6
Weiss, J.M.7
Wiltrout, R.H.8
Hollander, M.C.9
Yang, L.10
-
65
-
-
77955659643
-
CXCL10 expression and prognostic significance in stage II and III colorectal cancer
-
[CrossRef] [PubMed]
-
Jiang, Z.; Xu, Y.; Cai, S. CXCL10 expression and prognostic significance in stage II and III colorectal cancer. Mol. Biol. Rep. 2010, 37, 3029-3036. [CrossRef] [PubMed]
-
(2010)
Mol. Biol. Rep
, vol.37
, pp. 3029-3036
-
-
Jiang, Z.1
Xu, Y.2
Cai, S.3
-
66
-
-
84867019805
-
ColoGuideEx: A robust gene classifier specific for stage II colorectal cancer prognosis
-
[CrossRef] [PubMed]
-
Agesen, T.H.; Sveen, A.; Merok, M.A.; Lind, G.E.; Nesbakken, A.; Skotheim, R.I.; Lothe, R.A. ColoGuideEx: A robust gene classifier specific for stage II colorectal cancer prognosis. Gut 2012, 61, 1560-1567. [CrossRef] [PubMed]
-
(2012)
Gut
, vol.61
, pp. 1560-1567
-
-
Agesen, T.H.1
Sveen, A.2
Merok, M.A.3
Lind, G.E.4
Nesbakken, A.5
Skotheim, R.I.6
Lothe, R.A.7
-
67
-
-
84937072873
-
Oncogenic CXCL10 signaling drives metastasis development and poor clinical outcome
-
[CrossRef] [PubMed]
-
Wightman, S.C.; Uppal, A.; Pitroda, S.P.; Ganai, S.; Burnette, B.; Stack, M.; Oshima, G.; Khan, S.; Huang, X.; Posner, M.C.; et al. Oncogenic CXCL10 signaling drives metastasis development and poor clinical outcome. Br. J. Cancer 2015, 113, 327-335. [CrossRef] [PubMed]
-
(2015)
Br. J. Cancer
, vol.113
, pp. 327-335
-
-
Wightman, S.C.1
Uppal, A.2
Pitroda, S.P.3
Ganai, S.4
Burnette, B.5
Stack, M.6
Oshima, G.7
Khan, S.8
Huang, X.9
Posner, M.C.10
-
68
-
-
84862907729
-
Evaluation of CXCL10 as a novel serum marker for predicting liver metastasis and prognosis in colorectal cancer
-
[CrossRef] [PubMed]
-
Toiyama, Y.; Fujikawa, H.; Kawamura, M.; Matsushita, K.; Saigusa, S.; Tanaka, K.; Inoue, Y.; Uchida, K.; Mohri, Y.; Kusunoki, M. Evaluation of CXCL10 as a novel serum marker for predicting liver metastasis and prognosis in colorectal cancer. Int. J. Oncol. 2012, 40, 560-566. [CrossRef] [PubMed]
-
(2012)
Int. J. Oncol
, vol.40
, pp. 560-566
-
-
Toiyama, Y.1
Fujikawa, H.2
Kawamura, M.3
Matsushita, K.4
Saigusa, S.5
Tanaka, K.6
Inoue, Y.7
Uchida, K.8
Mohri, Y.9
Kusunoki, M.10
-
69
-
-
0034796261
-
Acceleration of intestinal polyposis through prostaglandin receptor EP2 in Apc D716 knockout mice
-
[CrossRef] [PubMed]
-
Sonoshita, M.; Takaku, K.; Sasaki, N.; Sugimoto, Y.; Ushikubi, F.; Narumiya, S.; Oshima, M.; Taketo, M.M. Acceleration of intestinal polyposis through prostaglandin receptor EP2 in Apc D716 knockout mice. Nat. Med. 2001, 7, 1048-1051. [CrossRef] [PubMed]
-
(2001)
Nat. Med
, vol.7
, pp. 1048-1051
-
-
Sonoshita, M.1
Takaku, K.2
Sasaki, N.3
Sugimoto, Y.4
Ushikubi, F.5
Narumiya, S.6
Oshima, M.7
Taketo, M.M.8
-
70
-
-
47549119148
-
+ CXC chemokine expression in benign and malignant colorectal conditions
-
[CrossRef] [PubMed]
-
+ CXC chemokine expression in benign and malignant colorectal conditions. BMC Cancer 2008, 8, 178. [CrossRef] [PubMed]
-
(2008)
BMC Cancer
, vol.8
, pp. 178
-
-
Rubie, C.1
Frick, V.O.2
Wagner, M.3
Schuld, J.4
Graber, S.5
Brittner, B.6
Bohle, R.M.7
Schilling, M.K.8
-
71
-
-
84155172374
-
Down-regulation of CXCL1 inhibits tumor growth in colorectal liver metastasis
-
[CrossRef] [PubMed]
-
Bandapalli, O.R.; Ehrmann, F.; Ehemann, V.; Gaida, M.; Macher-Goeppinger, S.; Wente, M.; Schimacher, P.; Brand, K. Down-regulation of CXCL1 inhibits tumor growth in colorectal liver metastasis. Cytokine 2012, 57, 46-53. [CrossRef] [PubMed]
-
(2012)
Cytokine
, vol.57
, pp. 46-53
-
-
Bandapalli, O.R.1
Ehrmann, F.2
Ehemann, V.3
Gaida, M.4
Macher-Goeppinger, S.5
Wente, M.6
Schimacher, P.7
Brand, K.8
-
72
-
-
23144461051
-
Genes thatmediate breast cancermetastasis to lung
-
[CrossRef] [PubMed]
-
Minn, A.J.; Gupta, G.P.; Siegel, P.M.; Bos, P.D.; Shu, W.; Giri, D.D.; Viale, A.; Olshen, A.B.; Gerald, W.L.; Masagué, J. Genes thatmediate breast cancermetastasis to lung. Nature 2005, 436, 518-524. [CrossRef] [PubMed]
-
(2005)
Nature
, vol.436
, pp. 518-524
-
-
Minn, A.J.1
Gupta, G.P.2
Siegel, P.M.3
Bos, P.D.4
Shu, W.5
Giri, D.D.6
Viale, A.7
Olshen, A.B.8
Gerald, W.L.9
Masagué, J.10
-
73
-
-
37349100945
-
+ myeloid cells that promote metastasis
-
[CrossRef] [PubMed]
-
+ myeloid cells that promote metastasis. Cancer Cell 2008, 13, 23-35. [CrossRef] [PubMed]
-
(2008)
Cancer Cell
, vol.13
, pp. 23-35
-
-
Yang, L.1
Huang, J.2
Ren, X.3
Gorska, A.E.4
Chytil, A.5
Aakre, M.6
Carbone, D.P.7
Matrisian, L.M.8
Richmond, A.9
Lin, P.C.10
-
74
-
-
84863099094
-
TGF-β receptor II loss promotes mammary carcinoma progression by Th17 dependent mechanisms
-
[CrossRef] [PubMed]
-
Novitskiy, S.V.; Pickup, M.W.; Gorska, A.E.; Owens, P.; Chytil, A.; Aakre, M.; Wu, H.; Shyr, Y.; Moses, H.L. TGF-β receptor II loss promotes mammary carcinoma progression by Th17 dependent mechanisms. Cancer Discov. 2011, 1, 1430-1441. [CrossRef] [PubMed]
-
(2011)
Cancer Discov
, vol.1
, pp. 1430-1441
-
-
Novitskiy, S.V.1
Pickup, M.W.2
Gorska, A.E.3
Owens, P.4
Chytil, A.5
Aakre, M.6
Wu, H.7
Shyr, Y.8
Moses, H.L.9
-
75
-
-
84857219446
-
+ myeloid-derived suppressor cells promote immune escape by limiting activated CD8 T-cell infiltration into the tumor microenvironment
-
[CrossRef] [PubMed]
-
+ myeloid-derived suppressor cells promote immune escape by limiting activated CD8 T-cell infiltration into the tumor microenvironment. Cancer Res. 2012, 72, 876-886. [CrossRef] [PubMed]
-
(2012)
Cancer Res
, vol.72
, pp. 876-886
-
-
Lesokhin, A.M.1
Hohl, T.M.2
Kitano, S.3
Cortez, C.4
Hirschhorn-Cymerman, D.5
Avogadri, F.6
Rizzuto, G.A.7
Lazarus, J.J.8
Pamer, E.G.9
Houghton, A.N.10
-
76
-
-
84874236258
-
Circulating and tumor-infiltrating myeloid-derived suppressor cells in patients with colorectal carcinoma
-
[CrossRef] [PubMed]
-
Zhang, B.; Wang, Z.; Wu, L.; Zhang, M.; Li, W.; Ding, J.; Zhu, J.; Wei, H.; Zhao, K. Circulating and tumor-infiltrating myeloid-derived suppressor cells in patients with colorectal carcinoma. PLoS ONE 2013, 8, e57114. [CrossRef] [PubMed]
-
(2013)
PLoS ONE
, vol.8
-
-
Zhang, B.1
Wang, Z.2
Wu, L.3
Zhang, M.4
Li, W.5
Ding, J.6
Zhu, J.7
Wei, H.8
Zhao, K.9
-
77
-
-
84901334642
-
Disruption of CXCR2-mediated MDSC tumor trafficking enhances anti-PD1 efficacy
-
[CrossRef] [PubMed]
-
Highfill, S.L.; Cui, Y.; Giles, A.J.; Smith, J.P.; Zhang, H.; Morse, E.; Kaplan, R.N.; Mackall, C.L. Disruption of CXCR2-mediated MDSC tumor trafficking enhances anti-PD1 efficacy. Sci. Transl. Med. 2014, 6, 237ra67. [CrossRef] [PubMed]
-
(2014)
Sci. Transl. Med
, vol.6
-
-
Highfill, S.L.1
Cui, Y.2
Giles, A.J.3
Smith, J.P.4
Zhang, H.5
Morse, E.6
Kaplan, R.N.7
Mackall, C.L.8
-
78
-
-
0030870251
-
Differential and regulated epression of C-X-C, C-C, and C-chemokines by human colon epithelial cells
-
[CrossRef] [PubMed]
-
Yang, S.K.; Eckmann, L.; Panja, A.; Kagnoff, M.F. Differential and regulated epression of C-X-C, C-C, and C-chemokines by human colon epithelial cells. Gastroenterology 1997, 113, 1214-1223. [CrossRef] [PubMed]
-
(1997)
Gastroenterology
, vol.113
, pp. 1214-1223
-
-
Yang, S.K.1
Eckmann, L.2
Panja, A.3
Kagnoff, M.F.4
-
79
-
-
24744438663
-
Induction of interleukin-8 preserves the angiogenic response in HIF-1-α-deficient colon cancer cells
-
[CrossRef] [PubMed]
-
Mizukami, Y.; Jo, W.S.; Duerr, E.M.; Gala, M.; Li, J.; Zhang, X.; Zimmer, M.A.; Iliopoulos, O.; Zukerberg, L.R.; Kohgo, Y.; et al. Induction of interleukin-8 preserves the angiogenic response in HIF-1-α-deficient colon cancer cells. Nat. Med. 2005, 11, 992-997. [CrossRef] [PubMed]
-
(2005)
Nat. Med
, vol.11
, pp. 992-997
-
-
Mizukami, Y.1
Jo, W.S.2
Duerr, E.M.3
Gala, M.4
Li, J.5
Zhang, X.6
Zimmer, M.A.7
Iliopoulos, O.8
Zukerberg, L.R.9
Kohgo, Y.10
-
80
-
-
79952471898
-
Interkeukin-8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line models
-
[CrossRef] [PubMed]
-
Ning, Y.; Manegold, P.C.; Hong, Y.K.; Zhang, W.; Pohl, A.; Lurje, G.; Winder, T.; Yang, D.; LaBonte, M.J.; Wilson, P.M.; et al. Interkeukin-8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line models. Int. J. Cancer 2011, 128, 2038-2049. [CrossRef] [PubMed]
-
(2011)
Int. J. Cancer
, vol.128
, pp. 2038-2049
-
-
Ning, Y.1
Manegold, P.C.2
Hong, Y.K.3
Zhang, W.4
Pohl, A.5
Lurje, G.6
Winder, T.7
Yang, D.8
LaBonte, M.J.9
Wilson, P.M.10
-
81
-
-
84871320421
-
Mice that express human interleukin-8 have increased mobilization of immature myeloid cells, which exacerbates inflammation and accelerates colon carcinogenesis
-
[CrossRef] [PubMed]
-
Asfaha, S.; Dubeykovskiy, A.N.; Tomita, H.; Yang, X.; Stokes, S.; Shibata, W.; Friedman, R.A.; Ariyama, H.; Dubeykovskaya, Z.A.; Muthupalani, S.; et al. Mice that express human interleukin-8 have increased mobilization of immature myeloid cells, which exacerbates inflammation and accelerates colon carcinogenesis. Gastroenterology 2013, 144, 155-166. [CrossRef] [PubMed]
-
(2013)
Gastroenterology
, vol.144
, pp. 155-166
-
-
Asfaha, S.1
Dubeykovskiy, A.N.2
Tomita, H.3
Yang, X.4
Stokes, S.5
Shibata, W.6
Friedman, R.A.7
Ariyama, H.8
Dubeykovskaya, Z.A.9
Muthupalani, S.10
-
82
-
-
84861440163
-
Interleukin-8 and its receptor CXCR2 in the tumour microenvironment promote colon cancer growth, progression and metastasis
-
[CrossRef] [PubMed]
-
Lee, Y.S.; Choi, I.; Ning, Y.; Kim, N.Y.; Khatchadourian, V.; Yang, D.; Chung, H.K.; Choi, D.; LaBonte, M.J.; Ladner, R.D.; et al. Interleukin-8 and its receptor CXCR2 in the tumour microenvironment promote colon cancer growth, progression and metastasis. Br. J. Cancer 2012, 106, 1833-1841. [CrossRef] [PubMed]
-
(2012)
Br. J. Cancer
, vol.106
, pp. 1833-1841
-
-
Lee, Y.S.1
Choi, I.2
Ning, Y.3
Kim, N.Y.4
Khatchadourian, V.5
Yang, D.6
Chung, H.K.7
Choi, D.8
LaBonte, M.J.9
Ladner, R.D.10
-
83
-
-
78649630055
-
Small molecule antagonists for CXCR2 and CXCR1 inhibit human colon cancer liver metastases
-
[CrossRef] [PubMed]
-
Varney, M.L.; Singh, S.; Li, A.; Mayer-Ezell, R.; Bond, R.; Singh, R.K. Small molecule antagonists for CXCR2 and CXCR1 inhibit human colon cancer liver metastases. Cancer Lett. 2011, 300, 180-188. [CrossRef] [PubMed]
-
(2011)
Cancer Lett
, vol.300
, pp. 180-188
-
-
Varney, M.L.1
Singh, S.2
Li, A.3
Mayer-Ezell, R.4
Bond, R.5
Singh, R.K.6
-
84
-
-
0036293981
-
Frequent loss of SMAD4/DPC4 protein in colorectal cancers
-
[CrossRef] [PubMed]
-
Salovaara, R.; Roth, S.; Loukola, A.; Launonen, V.; Sistonen, P.; Avizienyte, E.; Kristo, P.; Järvinen, H.; Souchelnytskyi, S.; Sarlomo-Rikala, M.; et al. Frequent loss of SMAD4/DPC4 protein in colorectal cancers. Gut 2002, 51, 56-59. [CrossRef] [PubMed]
-
(2002)
Gut
, vol.51
, pp. 56-59
-
-
Salovaara, R.1
Roth, S.2
Loukola, A.3
Launonen, V.4
Sistonen, P.5
Avizienyte, E.6
Kristo, P.7
Järvinen, H.8
Souchelnytskyi, S.9
Sarlomo-Rikala, M.10
-
85
-
-
34548575184
-
Loss of Smad4 expression predicts liver metastasis in human colorectal cancer
-
[CrossRef] [PubMed]
-
Losi, L.; Bouzourene, H.; Benhattar, J. Loss of Smad4 expression predicts liver metastasis in human colorectal cancer. Oncol. Rep. 2007, 17, 1095-1099. [CrossRef] [PubMed]
-
(2007)
Oncol. Rep
, vol.17
, pp. 1095-1099
-
-
Losi, L.1
Bouzourene, H.2
Benhattar, J.3
-
86
-
-
77952299708
-
Assessment of SMAD4, p53, and Ki-67 alterations as a predictor of liver metastasis in human colorectal cancer
-
[CrossRef]
-
Kawakami, M.; Yamaguchi, T.; Takahashi, K.; Matsumoto, H.; Yasutome, M.; Horiguchi, S.; Hayashi, Y.; Funata, N.; Mori, T. Assessment of SMAD4, p53, and Ki-67 alterations as a predictor of liver metastasis in human colorectal cancer. Surg. Today 2010, 40, 245-250. [CrossRef]
-
(2010)
Surg. Today
, vol.40
, pp. 245-250
-
-
Kawakami, M.1
Yamaguchi, T.2
Takahashi, K.3
Matsumoto, H.4
Yasutome, M.5
Horiguchi, S.6
Hayashi, Y.7
Funata, N.8
Mori, T.9
-
87
-
-
0032489508
-
Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes
-
[CrossRef]
-
Takaku, K.; Oshima, M.; Miyoshi, H.; Matsui, M.; Seldin, M.F.; Taketo, M.M. Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes. Cell 1998, 92, 645-656. [CrossRef]
-
(1998)
Cell
, vol.92
, pp. 645-656
-
-
Takaku, K.1
Oshima, M.2
Miyoshi, H.3
Matsui, M.4
Seldin, M.F.5
Taketo, M.M.6
-
88
-
-
84878639319
-
Control of both myeloid cell infiltration and angiogenesis by CCR1 promotes liver cancer metastasis development in mice
-
[CrossRef] [PubMed]
-
Rodero, M.P.; Auvynet, C.; Poupel, L.; Combadière, B.; Combadière, C. Control of both myeloid cell infiltration and angiogenesis by CCR1 promotes liver cancer metastasis development in mice. Neoplasia 2013, 15, 641-648. [CrossRef] [PubMed]
-
(2013)
Neoplasia
, vol.15
, pp. 641-648
-
-
Rodero, M.P.1
Auvynet, C.2
Poupel, L.3
Combadière, B.4
Combadière, C.5
-
89
-
-
84934307169
-
CCL2-induced chemokine cascade promotes breast cancer metastasis by enhancing retention of metastasis-associated macrophages
-
[CrossRef] [PubMed]
-
Kitamura, T.; Qian, B.Z.; Soong, D.; Cassetta, L.; Noy, R.; Sugano, G.; Kato, Y.; Li, J.; Pollard, J.W. CCL2-induced chemokine cascade promotes breast cancer metastasis by enhancing retention of metastasis-associated macrophages. J. Exp. Med. 2015, 212, 1043-1059. [CrossRef] [PubMed]
-
(2015)
J. Exp. Med
, vol.212
, pp. 1043-1059
-
-
Kitamura, T.1
Qian, B.Z.2
Soong, D.3
Cassetta, L.4
Noy, R.5
Sugano, G.6
Kato, Y.7
Li, J.8
Pollard, J.W.9
-
90
-
-
77955631528
-
CCR1 antagonists: What have we learned from clinical trials
-
[CrossRef] [PubMed]
-
Gladue, R.P.; Brown, M.F.; Zwillich, S.H. CCR1 antagonists: What have we learned from clinical trials. Curr. Top. Med. Chem. 2010, 10, 1268-1277. [CrossRef] [PubMed]
-
(2010)
Curr. Top. Med. Chem
, vol.10
, pp. 1268-1277
-
-
Gladue, R.P.1
Brown, M.F.2
Zwillich, S.H.3
-
91
-
-
84954197554
-
Successes and failures of chemokine-pathway targeting in rheumatoid arthritis
-
[CrossRef] [PubMed]
-
Szekanecz, Z.; Koch, A.E. Successes and failures of chemokine-pathway targeting in rheumatoid arthritis. Nat. Rev. Rheumatol. 2016, 12, 5-13. [CrossRef] [PubMed]
-
(2016)
Nat. Rev. Rheumatol
, vol.12
, pp. 5-13
-
-
Szekanecz, Z.1
Koch, A.E.2
-
92
-
-
80052397157
-
COX-2 inhibition alters the phenotype of tumor-associated macrophages from M2 to M1 in ApcMin/+ mouse polyps
-
[CrossRef] [PubMed]
-
Nakanishi, Y.; Nakatsuji, M.; Seno, H.; Ishizu, S.; Akitake-Kawano, R.; Kanda, K.; Ueo, T.; Komekado, H.; Kawada, M.; Minami, M.; et al. COX-2 inhibition alters the phenotype of tumor-associated macrophages from M2 to M1 in ApcMin/+ mouse polyps. Carcinogenesis 2011, 32, 1333-1339. [CrossRef] [PubMed]
-
(2011)
Carcinogenesis
, vol.32
, pp. 1333-1339
-
-
Nakanishi, Y.1
Nakatsuji, M.2
Seno, H.3
Ishizu, S.4
Akitake-Kawano, R.5
Kanda, K.6
Ueo, T.7
Komekado, H.8
Kawada, M.9
Minami, M.10
-
93
-
-
29244456458
-
Monocyte chemoattractant protein 1 and macrophage cyclooxygenase 2 expression in colonic adenoma
-
[CrossRef] [PubMed]
-
Tanaka, S.; Tatsuguchi, A.; Futagami, S.; Gudis, K.; Wada, K.; Seo, T.; Mitsui, K.; Yonezawa, M.; Nagata, K.; Fujimori, S.; et al. Monocyte chemoattractant protein 1 and macrophage cyclooxygenase 2 expression in colonic adenoma. Gut 2006, 55, 54-61. [CrossRef] [PubMed]
-
(2006)
Gut
, vol.55
, pp. 54-61
-
-
Tanaka, S.1
Tatsuguchi, A.2
Futagami, S.3
Gudis, K.4
Wada, K.5
Seo, T.6
Mitsui, K.7
Yonezawa, M.8
Nagata, K.9
Fujimori, S.10
-
94
-
-
79960411324
-
CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
-
[CrossRef] [PubMed]
-
Qian, B.Z.; Li, J.; Zhang, H.; Kitamura, T.; Zhang, J.; Campion, L.R.; Kaiser, E.A.; Snyder, L.A.; Pollard, J.W. CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature 2011, 475, 222-225. [CrossRef] [PubMed]
-
(2011)
Nature
, vol.475
, pp. 222-225
-
-
Qian, B.Z.1
Li, J.2
Zhang, H.3
Kitamura, T.4
Zhang, J.5
Campion, L.R.6
Kaiser, E.A.7
Snyder, L.A.8
Pollard, J.W.9
-
95
-
-
77951631347
-
Multiple roles of chemokine (C-C motif) ligand 2 in promoting prostate cancer growth
-
[CrossRef] [PubMed]
-
Zhang, J.; Lu, Y.; Pienta, K.J. Multiple roles of chemokine (C-C motif) ligand 2 in promoting prostate cancer growth. J. Natl. Cancer Inst. 2010, 102, 522-528. [CrossRef] [PubMed]
-
(2010)
J. Natl. Cancer Inst
, vol.102
, pp. 522-528
-
-
Zhang, J.1
Lu, Y.2
Pienta, K.J.3
-
96
-
-
84869179178
-
Linking tumor-associated macrophages, inflammation, and intestinal tumorigenesis: Role of MCP-1
-
[CrossRef] [PubMed]
-
McClellan, J.L.; Davis, J.M.; Steiner, J.L.; Enos, R.T.; Jung, S.H.; Carson, J.A.; Pena, M.M.; Carnevale, K.A.; Berger, F.G.; Murphy, E.A. Linking tumor-associated macrophages, inflammation, and intestinal tumorigenesis: Role of MCP-1. Am. J. Physiol. Gastrointest. Liver Physiol. 2012, 303, G1087-G1095. [CrossRef] [PubMed]
-
(2012)
Am. J. Physiol. Gastrointest. Liver Physiol
, vol.303
, pp. G1087-G1095
-
-
McClellan, J.L.1
Davis, J.M.2
Steiner, J.L.3
Enos, R.T.4
Jung, S.H.5
Carson, J.A.6
Pena, M.M.7
Carnevale, K.A.8
Berger, F.G.9
Murphy, E.A.10
-
97
-
-
70350227255
-
Blockade of a chemokine, CCL2, reduces chronic colitis-associated carcinogenesis in mice
-
[CrossRef] [PubMed]
-
Popivanova, B.K.; Kostadinova, F.I.; Furuichi, K.; Shamekh, M.M.; Kondo, T.; Wada, T.; Egashira, K.; Mukaida, N. Blockade of a chemokine, CCL2, reduces chronic colitis-associated carcinogenesis in mice. Cancer Res. 2009, 69, 7884-7892. [CrossRef] [PubMed]
-
(2009)
Cancer Res
, vol.69
, pp. 7884-7892
-
-
Popivanova, B.K.1
Kostadinova, F.I.2
Furuichi, K.3
Shamekh, M.M.4
Kondo, T.5
Wada, T.6
Egashira, K.7
Mukaida, N.8
-
98
-
-
84881519845
-
Beneficial impact of CCL2 and CCL12 neutralization on experimental malignant pleural effusion
-
[CrossRef] [PubMed]
-
Marazioti, A.; Kairi, C.A.; Spella, M.; Giannou, A.D.; Magkouta, S.; Giopanou, I.; Papaleonidopoulos, V.; Kalomenidis, I.; Snyder, L.A.; Kardamakis, D.; et al. Beneficial impact of CCL2 and CCL12 neutralization on experimental malignant pleural effusion. PLoS ONE 2013, 8, e71207. [CrossRef] [PubMed]
-
(2013)
PLoS ONE
, vol.8
-
-
Marazioti, A.1
Kairi, C.A.2
Spella, M.3
Giannou, A.D.4
Magkouta, S.5
Giopanou, I.6
Papaleonidopoulos, V.7
Kalomenidis, I.8
Snyder, L.A.9
Kardamakis, D.10
-
99
-
-
84879850236
-
Inflammatory monocyte mobilization decreases patient survival in pancreatic cancer: A role for targeting the CCL2/CCR2 axis
-
[CrossRef] [PubMed]
-
Sanford, D.E.; Belt, B.A.; Panni, R.Z.; Mayer, A.; Deshpande, A.D.; Carpenter, D.; Mitchem, J.B.; Plambeck-Suess, S.M.; Worley, L.A.; Goetz, B.D.; et al. Inflammatory monocyte mobilization decreases patient survival in pancreatic cancer: A role for targeting the CCL2/CCR2 axis. Clin. Cancer Res. 2013, 19, 3404-3415. [CrossRef] [PubMed]
-
(2013)
Clin. Cancer Res
, vol.19
, pp. 3404-3415
-
-
Sanford, D.E.1
Belt, B.A.2
Panni, R.Z.3
Mayer, A.4
Deshpande, A.D.5
Carpenter, D.6
Mitchem, J.B.7
Plambeck-Suess, S.M.8
Worley, L.A.9
Goetz, B.D.10
-
100
-
-
84915793974
-
Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis
-
[CrossRef] [PubMed]
-
Bonapace, L.; Coissieux, M.M.; Wyckoff, J.; Mertz, K.D.; Varga, Z.; Junt, T.; Bentires-Alj, M. Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis. Nature 2014, 515, 130-133. [CrossRef] [PubMed]
-
(2014)
Nature
, vol.515
, pp. 130-133
-
-
Bonapace, L.1
Coissieux, M.M.2
Wyckoff, J.3
Mertz, K.D.4
Varga, Z.5
Junt, T.6
Bentires-Alj, M.7
-
101
-
-
0033515827
-
Multilineage potential of adult human mesenchymeal stem cells
-
[CrossRef] [PubMed]
-
Pittenger, M.F. Multilineage potential of adult human mesenchymeal stem cells. Science 1999, 284, 143-147. [CrossRef] [PubMed]
-
(1999)
Science
, vol.284
, pp. 143-147
-
-
Pittenger, M.F.1
-
102
-
-
84869491266
-
Mesenchymal stem cell signaling in cancer progression
-
[CrossRef] [PubMed]
-
Torsvik, A.; Bjerkvig, R. Mesenchymal stem cell signaling in cancer progression. Cancer Treat. Rev. 2013, 39, 180-188. [CrossRef] [PubMed]
-
(2013)
Cancer Treat. Rev
, vol.39
, pp. 180-188
-
-
Torsvik, A.1
Bjerkvig, R.2
-
103
-
-
84873804360
-
Hypoxia-inducible factor-dependent breast cancer-mesenchymal stem cell bidirectional signaling promotes metastasis
-
[CrossRef] [PubMed]
-
Chaturvedi, P.; Gilkes, D.M.; Wong, C.C.L.; Luo, W.; Zhang, H.; Wei, H.; Takano, N.; Schito, L.; Levchenko, A.; Semenza, G.L. Hypoxia-inducible factor-dependent breast cancer-mesenchymal stem cell bidirectional signaling promotes metastasis. J. Clin. Investig. 2013, 123, 189-205. [CrossRef] [PubMed]
-
(2013)
J. Clin. Investig
, vol.123
, pp. 189-205
-
-
Chaturvedi, P.1
Gilkes, D.M.2
Wong, C.C.L.3
Luo, W.4
Zhang, H.5
Wei, H.6
Takano, N.7
Schito, L.8
Levchenko, A.9
Semenza, G.L.10
-
104
-
-
33749319703
-
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
-
[CrossRef] [PubMed]
-
Galon, J.; Costes, A.; Sanchez-Cabo, F.; Kirilovsky, A.; Mlecnik, B.; Lagorce-Pagès, C.; Tosolini, M.; Camus, M.; Berger, A.; Wind, P.; et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006, 313, 1960-1964. [CrossRef] [PubMed]
-
(2006)
Science
, vol.313
, pp. 1960-1964
-
-
Galon, J.1
Costes, A.2
Sanchez-Cabo, F.3
Kirilovsky, A.4
Mlecnik, B.5
Lagorce-Pagès, C.6
Tosolini, M.7
Camus, M.8
Berger, A.9
Wind, P.10
-
105
-
-
29144514645
-
Effector memory T cells, early metastasis, and survival in colorectal cancer
-
[CrossRef] [PubMed]
-
Pagès, F.; Berger, A.; Camus, M.; Sanchez-Cabo, F.; Costes, A.; Molidor, R.; Mlecnik, B.; Kirilovsky, A.; Nilsson, M.; Damotte, D.; et al. Effector memory T cells, early metastasis, and survival in colorectal cancer. N. Engl. J. Med. 2005, 353, 2654-2666. [CrossRef] [PubMed]
-
(2005)
N. Engl. J. Med
, vol.353
, pp. 2654-2666
-
-
Pagès, F.1
Berger, A.2
Camus, M.3
Sanchez-Cabo, F.4
Costes, A.5
Molidor, R.6
Mlecnik, B.7
Kirilovsky, A.8
Nilsson, M.9
Damotte, D.10
-
106
-
-
0032529466
-
+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer
-
[PubMed]
-
+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Cancer Res. 1998, 58, 3491-3494. [PubMed]
-
(1998)
Cancer Res
, vol.58
, pp. 3491-3494
-
-
Naito, Y.1
Saito, K.2
Shiiba, K.3
Ohuchi, A.4
Saigenji, K.5
Nagura, H.6
Ohtani, H.7
-
107
-
-
83755183659
-
CCL5 neutralization restricts cancer growth and potentiates the targeting of PDGFRβ in colorectal carcinoma
-
[CrossRef] [PubMed]
-
Cambien, B.; Richard-Fiardo, P.; Karimdjee, B.F.; Martini, V.; Ferrua, B.; Pitard, B.; Schmid-Antomarchi, H.; Schimid-Alliana, A. CCL5 neutralization restricts cancer growth and potentiates the targeting of PDGFRβ in colorectal carcinoma. PLoS ONE 2011, 6, e28842. [CrossRef] [PubMed]
-
(2011)
PLoS ONE
, vol.6
-
-
Cambien, B.1
Richard-Fiardo, P.2
Karimdjee, B.F.3
Martini, V.4
Ferrua, B.5
Pitard, B.6
Schmid-Antomarchi, H.7
Schimid-Alliana, A.8
-
108
-
-
79951815749
-
Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, Th2, Treg, Th17) in patients with colorectal cancer
-
[CrossRef] [PubMed]
-
Tosolini, M.; Kirilovsky, A.; Mlecnik, B.; Fredriksen, T.; Mauger, S.; Bindea, G.; Berger, A.; Bruneval, P.; Fridman, W.H.; Pagès, F.; et al. Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, Th2, Treg, Th17) in patients with colorectal cancer. Cancer Res. 2011, 71, 1263-1271. [CrossRef] [PubMed]
-
(2011)
Cancer Res
, vol.71
, pp. 1263-1271
-
-
Tosolini, M.1
Kirilovsky, A.2
Mlecnik, B.3
Fredriksen, T.4
Mauger, S.5
Bindea, G.6
Berger, A.7
Bruneval, P.8
Fridman, W.H.9
Pagès, F.10
-
109
-
-
84883745262
-
An interleukin-17-mediated paracrine network promotes tumor resistance to anti-angiogenic therapy
-
[CrossRef] [PubMed]
-
Chung, A.S.; Wu, X.; Zhuang, G.; Ngu, H.; Kasman, I.; Zhang, J.; Vernes, J.M.; Jiang, Z.; Meng, Y.G.; Peale, F.V.; et al. An interleukin-17-mediated paracrine network promotes tumor resistance to anti-angiogenic therapy. Nat. Med. 2013, 19, 1114-1123. [CrossRef] [PubMed]
-
(2013)
Nat. Med
, vol.19
, pp. 1114-1123
-
-
Chung, A.S.1
Wu, X.2
Zhuang, G.3
Ngu, H.4
Kasman, I.5
Zhang, J.6
Vernes, J.M.7
Jiang, Z.8
Meng, Y.G.9
Peale, F.V.10
-
110
-
-
33645286546
-
Regulatory T cells, tumour immunity and immunotherapy
-
[CrossRef] [PubMed]
-
Zou, W. Regulatory T cells, tumour immunity and immunotherapy. Nat. Rev. Immunol. 2006, 6, 295-307. [CrossRef] [PubMed]
-
(2006)
Nat. Rev. Immunol
, vol.6
, pp. 295-307
-
-
Zou, W.1
-
111
-
-
58849124250
-
CCR6 Regulates the Migration of Inflammatory and Regulatory T Cells
-
[CrossRef]
-
Yamazaki, T.; Yang, X.O.; Chung, Y.; Fukunaga, A.; Nurieva, R.; Pappu, B.; Martin-Orozco, N.; Kang, H.S.; Ma, L.; Panopoulos, A.D.; et al. CCR6 Regulates the Migration of Inflammatory and Regulatory T Cells. J. Immunol. 2008, 81, 8391-8401. [CrossRef]
-
(2008)
J. Immunol
, vol.81
, pp. 8391-8401
-
-
Yamazaki, T.1
Yang, X.O.2
Chung, Y.3
Fukunaga, A.4
Nurieva, R.5
Pappu, B.6
Martin-Orozco, N.7
Kang, H.S.8
Ma, L.9
Panopoulos, A.D.10
-
112
-
-
79955040909
-
+ regulatory T cells in the microenvironments of chronic inflammation and cancer
-
[CrossRef] [PubMed]
-
+ regulatory T cells in the microenvironments of chronic inflammation and cancer. J. Immunol. 2011, 186, 4388-4395. [CrossRef] [PubMed]
-
(2011)
J. Immunol
, vol.186
, pp. 4388-4395
-
-
Kryczek, I.1
Wu, K.2
Zhao, E.3
Wei, S.4
Vatan, L.5
Szeliga, W.6
Huang, E.7
Greenson, J.8
Chang, A.9
Rolinski, J.10
-
113
-
-
67650022084
-
The chemokine CCL20 and its receptor CCR6 in human malignancy with focus on colorectal cancer
-
[CrossRef] [PubMed]
-
Ghadjar, P.; Rubie, C.; Aebersold, D.M.; Keilholz, U. The chemokine CCL20 and its receptor CCR6 in human malignancy with focus on colorectal cancer. Int. J. Cancer 2009, 125, 741-745. [CrossRef] [PubMed]
-
(2009)
Int. J. Cancer
, vol.125
, pp. 741-745
-
-
Ghadjar, P.1
Rubie, C.2
Aebersold, D.M.3
Keilholz, U.4
-
114
-
-
84883026021
-
CCR6/CCL20 chemokine expression profile in distinct colorectal malignancies
-
[CrossRef] [PubMed]
-
Frick, V.O.; Rubie, C.; Kölsch, K.; Wagner, M.; Ghadjar, P.; Graeber, S.; Glanemann, M. CCR6/CCL20 chemokine expression profile in distinct colorectal malignancies. Scand. J. Immunol. 2013, 78, 298-305. [CrossRef] [PubMed]
-
(2013)
Scand. J. Immunol
, vol.78
, pp. 298-305
-
-
Frick, V.O.1
Rubie, C.2
Kölsch, K.3
Wagner, M.4
Ghadjar, P.5
Graeber, S.6
Glanemann, M.7
-
115
-
-
0032801427
-
Chemokine receptor expression by human intestinal epithelial cells
-
[CrossRef] [PubMed]
-
Dwinell, M.B.; Eckmann, L.; Leopard, J.D.; Varki, N.M.; Kagnoff, M.F. Chemokine receptor expression by human intestinal epithelial cells. Gastroenterology 1999, 117, 359-367. [CrossRef] [PubMed]
-
(1999)
Gastroenterology
, vol.117
, pp. 359-367
-
-
Dwinell, M.B.1
Eckmann, L.2
Leopard, J.D.3
Varki, N.M.4
Kagnoff, M.F.5
-
116
-
-
33646350054
-
Chemokine receptor CCR6 expression level and liver metastases in colorectal cancer
-
[CrossRef] [PubMed]
-
Ghadjar, P.; Coupland, S.E.; Na, I.K.; Noutsias, M.; Letsch, A.; Stroux, A.; Bauer, S.; Buhr, H.J.; Thiel, E.; Scheibenbogen, C.; et al. Chemokine receptor CCR6 expression level and liver metastases in colorectal cancer. J. Clin. Oncol. 2006, 24, 1910-1916. [CrossRef] [PubMed]
-
(2006)
J. Clin. Oncol
, vol.24
, pp. 1910-1916
-
-
Ghadjar, P.1
Coupland, S.E.2
Na, I.K.3
Noutsias, M.4
Letsch, A.5
Stroux, A.6
Bauer, S.7
Buhr, H.J.8
Thiel, E.9
Scheibenbogen, C.10
-
117
-
-
84872261751
-
Macrophage inflammatory protein-3 alpha (MIP-3α) is a novel serum prognostic marker in patients with colorectal cancer
-
[CrossRef] [PubMed]
-
Iwata, T.; Tanaka, K.; Inoue, Y.; Toiyama, Y.; Hiro, J.; Fujikawa, H.; Okugawa, Y.; Uchida, K.; Mohri, Y.; Kusunoki, M. Macrophage inflammatory protein-3 alpha (MIP-3α) is a novel serum prognostic marker in patients with colorectal cancer. J. Surg. Oncol. 2013, 107, 160-166. [CrossRef] [PubMed]
-
(2013)
J. Surg. Oncol
, vol.107
, pp. 160-166
-
-
Iwata, T.1
Tanaka, K.2
Inoue, Y.3
Toiyama, Y.4
Hiro, J.5
Fujikawa, H.6
Okugawa, Y.7
Uchida, K.8
Mohri, Y.9
Kusunoki, M.10
-
118
-
-
84901437996
-
CCR6, the sole receptor for the chemokine CCL20, promotes spontaneous intestinal tumorigenesis
-
[CrossRef] [PubMed]
-
Nandi, B.; Pai, C.; Huang, Q.; Prabhala, R.H.; Munshi, N.C.; Gold, J.S. CCR6, the sole receptor for the chemokine CCL20, promotes spontaneous intestinal tumorigenesis. PLoS ONE 2014, 9, e97566. [CrossRef] [PubMed]
-
(2014)
PLoS ONE
, vol.9
-
-
Nandi, B.1
Pai, C.2
Huang, Q.3
Prabhala, R.H.4
Munshi, N.C.5
Gold, J.S.6
-
119
-
-
84858780815
-
Cancer immunotherapy via dendritic cells
-
[CrossRef] [PubMed]
-
Palucka, K.; Banchereau, J. Cancer immunotherapy via dendritic cells. Nat. Rev. Cancer 2012, 12, 265-277. [CrossRef] [PubMed]
-
(2012)
Nat. Rev. Cancer
, vol.12
, pp. 265-277
-
-
Palucka, K.1
Banchereau, J.2
-
120
-
-
84907873981
-
Antitumor efficacy of CC motif chemokine ligand 19 in colorectal cancer
-
[CrossRef] [PubMed]
-
Lu, J.; Zhao, J.; Feng, H.; Wang, P.; Zhang, Z.; Zong, Y.; Ma, J.; Zheng, M.; Lu, A. Antitumor efficacy of CC motif chemokine ligand 19 in colorectal cancer. Dig. Dis. Sci. 2014, 59, 2153-2162. [CrossRef] [PubMed]
-
(2014)
Dig. Dis. Sci
, vol.59
, pp. 2153-2162
-
-
Lu, J.1
Zhao, J.2
Feng, H.3
Wang, P.4
Zhang, Z.5
Zong, Y.6
Ma, J.7
Zheng, M.8
Lu, A.9
-
121
-
-
61449492725
-
Decreased expression of the chemokine CCL21 in human colorectal adenocarcinomas
-
[PubMed]
-
Mumtaz, M.; Wagsater, D.; Lofgren, S.; Hugander, A.; Zar, N.; Dimberg, J. Decreased expression of the chemokine CCL21 in human colorectal adenocarcinomas. Oncol. Rep. 2009, 21, 153-158. [PubMed]
-
(2009)
Oncol. Rep
, vol.21
, pp. 153-158
-
-
Mumtaz, M.1
Wagsater, D.2
Lofgren, S.3
Hugander, A.4
Zar, N.5
Dimberg, J.6
-
122
-
-
84856545781
-
Tumor infiltration by T lymphocytes expressing chemokine receptor 7 (CCR7) is predictive of favorable outcome in patients with advanced colorectal carcinoma
-
[CrossRef] [PubMed]
-
Correale, P.; Rotundo, M.S.; Botta, C.; del Vecchio, M.T.; Ginanneschi, C.; Licchetta, A.; Conca, R.; Apollinari, S.; de Luca, F.; Tassone, P.; et al. Tumor infiltration by T lymphocytes expressing chemokine receptor 7 (CCR7) is predictive of favorable outcome in patients with advanced colorectal carcinoma. Clin. Cancer Res. 2012, 18, 850-857. [CrossRef] [PubMed]
-
(2012)
Clin. Cancer Res
, vol.18
, pp. 850-857
-
-
Correale, P.1
Rotundo, M.S.2
Botta, C.3
del Vecchio, M.T.4
Ginanneschi, C.5
Licchetta, A.6
Conca, R.7
Apollinari, S.8
de Luca, F.9
Tassone, P.10
-
123
-
-
23244440503
-
Prediction of lymph node metastasis in colorectal carcinoma by expressionof chemokine receptor CCR7
-
[CrossRef] [PubMed]
-
Günther, K.; Leier, J.; Henning, G.; Dimmler, A.; Weiβbach, R.; Hohenberger, W.; Förster, R. Prediction of lymph node metastasis in colorectal carcinoma by expressionof chemokine receptor CCR7. Int. J. Cancer 2005, 116, 726-733. [CrossRef] [PubMed]
-
(2005)
Int. J. Cancer
, vol.116
, pp. 726-733
-
-
Günther, K.1
Leier, J.2
Henning, G.3
Dimmler, A.4
Weiβbach, R.5
Hohenberger, W.6
Förster, R.7
-
124
-
-
78649936769
-
The CCL21/CCR7 pathway plays a key role in human colon cancer metastasis through regulation of matrix metalloproteinase-9
-
[CrossRef] [PubMed]
-
Li, J.; Sun, R.; Tao, K.; Wang, G. The CCL21/CCR7 pathway plays a key role in human colon cancer metastasis through regulation of matrix metalloproteinase-9. Dig. Liver Dis. 2011, 43, 40-47. [CrossRef] [PubMed]
-
(2011)
Dig. Liver Dis
, vol.43
, pp. 40-47
-
-
Li, J.1
Sun, R.2
Tao, K.3
Wang, G.4
-
125
-
-
35348903902
-
Eotaxin-2 and colorectal cancer: A potential target for immune therapy
-
[CrossRef] [PubMed]
-
Cheadle, E.J.; Riyad, K.; Subar, D.; Rothwell, D.G.; Ashton, G.; Batha, H.; Sherlock, D.J.; Hawkins, R.E.; Gilham, D.E. Eotaxin-2 and colorectal cancer: A potential target for immune therapy. Clin. Cancer Res. 2007, 13, 5719-5728. [CrossRef] [PubMed]
-
(2007)
Clin. Cancer Res
, vol.13
, pp. 5719-5728
-
-
Cheadle, E.J.1
Riyad, K.2
Subar, D.3
Rothwell, D.G.4
Ashton, G.5
Batha, H.6
Sherlock, D.J.7
Hawkins, R.E.8
Gilham, D.E.9
-
126
-
-
78049517433
-
Mesenchymal stem cells enhance growth and metastasis of colon cancer
-
[CrossRef] [PubMed]
-
Shinagawa, K.; Kitadai, Y.; Tanaka, M.; Sumida, T.; Kodama, M.; Higashi, Y.; Tanaka, S.; Yasui, W.; Chayama, K. Mesenchymal stem cells enhance growth and metastasis of colon cancer. Int. J. Cancer 2010, 127, 2323-2333. [CrossRef] [PubMed]
-
(2010)
Int. J. Cancer
, vol.127
, pp. 2323-2333
-
-
Shinagawa, K.1
Kitadai, Y.2
Tanaka, M.3
Sumida, T.4
Kodama, M.5
Higashi, Y.6
Tanaka, S.7
Yasui, W.8
Chayama, K.9
-
127
-
-
84878011400
-
The use of hypoxic cultured mesenchymal stem cell for oncolytic virus therapy
-
[CrossRef] [PubMed]
-
Huang, Y.F.; Chen, M.J.; Wu, M.H.; Hung, S.C. The use of hypoxic cultured mesenchymal stem cell for oncolytic virus therapy. Cancer Gene Ther. 2013, 20, 308-316. [CrossRef] [PubMed]
-
(2013)
Cancer Gene Ther
, vol.20
, pp. 308-316
-
-
Huang, Y.F.1
Chen, M.J.2
Wu, M.H.3
Hung, S.C.4
-
128
-
-
84939489511
-
The complex role of chemokines in cancer: The case of the CX3CL1/CX3CR1 axis
-
1st ed.; iConcept Press Ltd.: Madrid, Spain, Chapter 8
-
Tardáguila, M.; Mañes, S. The complex role of chemokines in cancer: The case of the CX3CL1/CX3CR1 axis. In Oncology Theory & Practice, 1st ed.; iConcept Press Ltd.: Madrid, Spain, 2014; Chapter 8.
-
(2014)
Oncology Theory & Practice
-
-
Tardáguila, M.1
Mañes, S.2
-
129
-
-
34047181954
-
Tissue-specific differential antitumour effect of molecular forms of fractalkine in a mouse model of metastatic colon cancer
-
[CrossRef] [PubMed]
-
Vitale, S.; Cambien, B.; Karimdjee, B.F.; Barthel, R.; Staccini, P.; Luci, C.; Breittmayer, B.; Anjuère, F.; Schmid-Alliana, A.; Schmid-Antomarchi, H. Tissue-specific differential antitumour effect of molecular forms of fractalkine in a mouse model of metastatic colon cancer. Gut 2007, 56, 365-372. [CrossRef] [PubMed]
-
(2007)
Gut
, vol.56
, pp. 365-372
-
-
Vitale, S.1
Cambien, B.2
Karimdjee, B.F.3
Barthel, R.4
Staccini, P.5
Luci, C.6
Breittmayer, B.7
Anjuère, F.8
Schmid-Alliana, A.9
Schmid-Antomarchi, H.10
-
130
-
-
20444479181
-
The high expression of Fractalkine results in a better prognosis for colorectal cancer patients
-
[CrossRef] [PubMed]
-
Ohta, M.; Tanaka, F.; Yamaguchi, H.; Sadanaga, N.; Inoue, H.; Mori, M. The high expression of Fractalkine results in a better prognosis for colorectal cancer patients. Int. J. Oncol. 2005, 26, 41-47. [CrossRef] [PubMed]
-
(2005)
Int. J. Oncol
, vol.26
, pp. 41-47
-
-
Ohta, M.1
Tanaka, F.2
Yamaguchi, H.3
Sadanaga, N.4
Inoue, H.5
Mori, M.6
-
131
-
-
84932628341
-
PD-1 blockade in tumors with mismatch-repair deficiency
-
[CrossRef] [PubMed]
-
Le, D.T.; Uram, J.N.; Wang, H.; Barlett, B.R.; Kemberling, H.; Eyring, A.D.; Skora, A.D.; Luber, B.S.; Azad, N.S.; Laheru, D.; et al. PD-1 blockade in tumors with mismatch-repair deficiency. N. Eng. J. Med. 2015, 372, 2509-2520. [CrossRef] [PubMed]
-
(2015)
N. Eng. J. Med
, vol.372
, pp. 2509-2520
-
-
Le, D.T.1
Uram, J.N.2
Wang, H.3
Barlett, B.R.4
Kemberling, H.5
Eyring, A.D.6
Skora, A.D.7
Luber, B.S.8
Azad, N.S.9
Laheru, D.10
-
132
-
-
84863922124
-
Comprehensive molecular characterization of human colon and rectal cancer
-
Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 2012, 487, 330-337.
-
(2012)
Nature
, vol.487
, pp. 330-337
-
-
Cancer Genome Atlas Network1
|